新和成(002001) - 2025 Q2 - 季度业绩预告

Current Period Performance Forecast The company forecasts a significant year-over-year increase in net profit and earnings per share for the first half of 2025 Performance Forecast Period This performance forecast covers the period from January 1, 2025, to June 30, 2025 - The performance forecast period is January 1, 2025, to June 30, 2025[3] Estimated Performance The company expects net profit attributable to shareholders and net profit after non-recurring gains/losses to increase by over 50% year-over-year for H1 2025, with basic earnings per share also significantly rising - The company anticipates a year-over-year increase in performance for the current reporting period[3] H1 2025 Performance Forecast | Item | Current Period Forecast (10,000 CNY) | Year-over-Year Growth | Prior Period (10,000 CNY) | | :--------------------------------- | :--------------------------- | :-------------------- | :------------------------ | | Net Profit Attributable to Shareholders | 330,000—375,000 | 50%—70% | 220,436 | | Net Profit After Non-Recurring Items | 325,000—370,000 | 51%—71% | 215,746 | | Basic Earnings Per Share (CNY/share) | 1.07—1.22 | - | 0.71 | Communication with Accounting Firm The financial data presented in this performance forecast has not been audited by a certified public accountant Audit Status Explanation The financial data involved in this performance forecast has not been audited by a certified public accountant - The financial data related to this performance forecast has not been audited by a certified public accountant[4] Explanation of Performance Changes The company's performance growth is primarily attributed to increased sales volume and prices of key nutritional products during the reporting period Drivers of Performance Growth During the reporting period, both sales volume and sales prices of the company's main nutritional products increased year-over-year, driving improved operating performance - During the reporting period, both sales volume and sales prices of key nutritional products increased year-over-year[5] - The simultaneous increase in sales volume and price was the primary reason for the improvement in operating performance[5] Risk Warning This performance forecast is a preliminary estimate, and investors are advised to consider investment risks as final data will be in the H1 2025 report Limitations of Performance Forecast and Investment Risks This performance forecast represents preliminary estimates by the company's finance department, with final financial data subject to the 2025 semi-annual report, urging investors to be aware of investment risks - This performance forecast is a preliminary estimate by the company's finance department[6] - The definitive financial data will be based on the company's 2025 semi-annual report[6] - Investors are kindly advised to exercise caution regarding investment risks[6]